title: Protocol for investigation of possible soya allergy in patients being considered for treatment with isotretinoin or alitretinoin.
authors.affiliation: Department of Dermatology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK. katrin.alden@wales.nhs.uk.
authors.forename: K
authors.initials: K
authors.lastname: Alden
authors.affiliation: Department of Dermatology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
authors.forename: M M U
authors.initials: MM
authors.lastname: Chowdhury
authors.affiliation: Department of Immunology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
authors.forename: P E
authors.initials: PE
authors.lastname: Williams
authors.affiliation: Department of Dermatology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, UK.
authors.forename: M
authors.initials: M
authors.lastname: Kalavala
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy; D000328:Adult; D000077556:Alitretinoin; D002985:Clinical Protocols; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D005512:Food Hypersensitivity / Q000175:diagnosis*; D006801:Humans; D015474:Isotretinoin / Q000009:adverse effects*; D021184:Nut Hypersensitivity / Q000175:diagnosis; D013025:Glycine max / Q000009:adverse effects*; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D003879:Dermatologic Agents; D000077556:Alitretinoin; D014212:Tretinoin; D015474:Isotretinoin